Future Technologies

Single Port Surgery
Driven by the media and patient communities, single port surgery is rapidly becoming “the next emerging technology” in minimally invasive surgery. The promise of better cosmetic outcomes, reduced pain, and fewer potential complications has both academic and community surgeons seeking technology that will enable them to safely and effectively perform laparoscopic surgery through a single port, often in the umbilicus. Instead of advancing this effort, today’s technology has limited it. Until now. Learn More >

Shaping the future of laparoscopy
SurgiQuest AirSeal^® DPS (Dynamic Pressure System) is the only technology capable of maintaining pneumoperitoneum while accepting multiple instruments of varying shape and size through a single channel. With AirSeal, specialized and standard instruments can now be used to address the current challenges facing surgeons pursuing single port surgery. This puts SurgiQuest technology at a whole new level and our company in a unique position to enable and dominate this market.

Endoluminal and Transluminal (N.O.T.E.S.) Surgery
For extremely large and underserved patient populations — individuals with diseases like obesity and metabolic syndrome — endoluminal and N.O.T.E.S. therapies hold great promise.

Promising news for a growing population
Continued clinical research and investigational surgery offer encouraging news for treating these growing patient populations and alleviating a strain on our healthcare system. While surgery has not been the conventional way to treat these diseases, minimally invasive endoscopic approaches have the potential to treat the root causes of diseases in new ways.